Live feed
Filing
SC 13D
SC 13D0001193125-20-270273·BridgeBio Pharma, Inc.
Schedule 13D ownership disclosure
BRIDGEBIO PHARMA INC
Security class unavailable · CUSIP: 10806X102
Event date: 2020-10-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 36.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-270273
- Form type
- SC 13D
- Filer
- BridgeBio Pharma, Inc.
- CIK
- CIK 1743881
- Filed
- Oct 15, 2020
- Reporting period
- Oct 05, 2020
- Description
- Schedule 13D beneficial ownership